Please assess the completion status of the following clinical trial:

Trial Title: Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosed with CD and CPF (defined as a fistula meeting any of the following criteria: high location \[high intersphincteric, high transsphincteric, extrasphincteric, or suprasphincteric\], multiple external openings, perianal abscess, anal stenosis, or proctitis).~2. Has tried and failed at least one prior treatment for CPF.~3. Starting a new pharmacological or surgical treatment for CPF.~Exclusion Criteria:~1. Diagnosed with indeterminate/unspecified type of inflammatory bowel disease (IBD).~2. Diagnosed with ulcerative colitis.~3. Diagnosed with fistula other than CPF (example rectovaginal).~4. Treated with darvadstrocel or other stem cells-based therapies within the eligibility period.~5. Previous fecal incontinence.~6. Lost to site follow-up for reasons other than death.~7. Participates or plans to participate in any interventional clinical trial.~8. Non fluent in Spanish.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- All Participants (Type: None): Participants diagnosed with CD and CPF from approximately 20 Spanish hospitals, who will initiate medical or surgical treatment for their CPF within the eligibility period from Sep 2020 to Sep 2021, will be observed prospectively for approximately 31 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).